Dr. Roy Chemaly, MD

• Medical Microbiology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Saint Joseph's University / Faculty Of Medicine

  Medical School, 1992

• Delay of Alternative Antiviral Therapy and Poor Outcomes of Acyclovir-Resistant Herpes Simplex Virus Infections in Recipients of Allogeneic Stem Cell Transplant, 2018-03-13

• Clinical and Economic Burden of Pre-emptive Therapy of Cytomegalovirus Infection in Hospitalized Allogeneic Hematopoietic Cell Transplant Recipients, 2019-09-03

• Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients, 2020-04-21

• General and Virus-Specific Immune Cell Reconstitution Following Double Cord Blood Transplantation, 2015-02-20

• Pulmonary impairment following respiratory viral infections is associated with high mortality in allogeneic hematopoietic cell transplant recipients, 2018-12-03

• Adenoviral Infections in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Single Center Experience, 2013-03-18

• Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections, 2018-05-17

• A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL, 2016-05-05

• Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program, 2021-01-11

• Are Cancer Patients at Higher Risk of Death With COVID-19?, 2020-03-17

• Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index, 2015-11-27

• Genomic and Functional Characterization of Vancomycin-Resistant Enterococci-Specific Bacteriophages in theGalleria mellonellaWax Moth Larvae Model, 2022-07-30

• 940. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia, 2021-12-04

• Parainfluenza Virus Infections in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients: A Systematic Review, 2015-11-12

• International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship, 2023-01-30

• Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control, 2020-08-03

• Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis, 2015-11-10

• Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies, 2018-09-21

• Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults, 2019-03-29

• Symptomatic BK Virus Infection Is Associated with Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients, 2016-03-02

• 15. Evaluation of Retained Immunity forTetanus-DiphtheriaandPneumococcalVaccines in Recipients of Cellular Therapies, 2021-12-04

• Burden of Human Metapneumovirus Infections in Cancer Patients: Risk Factors and Outcomes, 2017-02-08

• Staphylococcus lugdunensis Infections, filling in the gaps: a 3-year, Retrospective Review from a Comprehensive Cancer Center, 2016-11-24

• Human Metapneumovirus Infections in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients: A Systematic Review, 2016-05-31

• ActiveMycobacterium tuberculosisinfection at a comprehensive cancer center, 2006-2014, 2019-11-06

• 922. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis, 2021-12-04

• Mucus-degrading Bacteroides link carbapenems to aggravated graft-versushost disease, 2022-09-29

• HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant, 2019-01-23

• Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center, 2020-11-13

• 1060. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections - First Case Series, 2021-12-04

• Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients, 2021-05-26

• The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study, 2016-12-12

• 22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome, 2021-12-04

• Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms, 2017-10-10